Unsaturated but not saturated fatty acids induce transcriptional regulation of CCL2 in pancreatic acini. A potential role in acute pancreatitis  by Mateu, A. et al.
Biochimica et Biophysica Acta 1852 (2015) 2671–2677
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbad isUnsaturated but not saturated fatty acids induce transcriptional
regulation of CCL2 in pancreatic acini. A potential role in
acute pancreatitisA. Mateu, I. De Dios, M.A. Manso, L. Ramudo ⁎
Department of Physiology and Pharmacology, University of Salamanca, 37007 Salamanca, SpainAbbreviations: AP, acute pancreatitis; CCL2, chemok
extracellular signal-regulated kinase; FA, fatty acid; JAK
terminal kinase; LA, linoleic acid; MAPKs, mitogen-activa
clear factor-kappa B; OA, oleic acid; PA, palmitic acid; P
activated receptor; SA, stearic acid; SFA, saturated fatty ac
activator of transcription; UFA, unsaturated fatty acid; 1
prostaglandin J2
⁎ Corresponding author at: Departamento Fisiolo
Departamental, Campus Miguel de Unamuno, 37007 Sala
E-mail address: ramudo@usal.es (L. Ramudo).
http://dx.doi.org/10.1016/j.bbadis.2015.09.015
0925-4439/© 2015 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 8 July 2015
Received in revised form 14 September 2015
Accepted 21 September 2015






Unsaturated fatty acidsFatty acids (FAs) are massively released from peripancreatic fat during acute pancreatitis (AP) and they were
shown, as a whole, to induce inﬂammatory response in pancreatic acini. We investigated the mechanisms trig-
gered by themajor saturated FAs (SFAs) and unsaturated FAs (UFAs) inmodulating the expression of chemokine
(C–Cmotif) ligand 2 (CCL2) in acinar cells. Pancreatic acini of control rats were treatedwith palmitic acid (PA) or
stearic acid (SA), as SFAs, or oleic acid (OA) or linoleic acid (LA), as UFAs. By using speciﬁc inhibitors, the involve-
ment of MAPKs (JNK, ERK, p38), JAK, NF-κB and STAT3 pathways was assessed. The role of PPARγ pathway was
studied by using 15-Deoxy-Δ(12,14)-prostaglandin J(2) (15d-PGJ2). CCL2 mRNA was analyzed by qRT-PCR. By
western blot, phosphorylated forms of MAPKs and JAK as well as IκB-α were analyzed in cytoplasm and p65-
NF-κB and phospho-STAT3 in nucleus. No effect was found in PA- or SA-treated acini. Conversely, in response
toOA or LA,MAPKs and JAK acted as upstream signals, driving the CCL2 up-regulation transcriptionallymediated
by the synergic action of NF-κB and STAT3. By blocking the activation of NF-κB and STAT3, 15d-PGJ2 totally
inhibited the OA- and LA-induced CCL2 overexpression. We conclude that the most common UFAs, but not the
SFAs, represented in peripancreatic fat and released during AP, are capable of up-regulating the acinar expression
of CCL2, which depends on the activation of MAPK/JAK-mediated NF-κB and STAT3 pathways. By targeting both
transcription factors, PPARγ agonists could be indicated as potential therapy in AP.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Elevated concentration of free fatty acids (FAs) in plasma is a com-
mon feature in inﬂammatory diseases, including acute pancreatitis
(AP) [1,2]. Regardless of AP etiology, digestive enzymes, such as lipases
and phospholipase A2, are leaked out from the injured acinar cells into
the pancreatic interstitium and blood stream [3]. As a result of the lipase
action on peripancreatic adipose tissue, high amounts of FAs are gener-
ated, an event associated with multisystem organ failure during severe
forms of AP [4,5] which is especially relevant in obesity. With regard to
this, obesity is considered a risk factor that aggravates the progression of
AP in humans [5–7] and animal models [8,9], although the underlying
mechanisms are not fully understood.ine (C–C motif) ligand 2; ERK,
, Janus kinase; JNK, Jun NH2-
ted protein kinases; NF-κB, nu-
PAR, peroxisome proliferator-
id; STAT, signal transducer and
5d-PGJ2, 15-Deoxy-Δ(12,14)-
gía y Farmacología, Ediﬁcio
manca, Spain.Noxious effects have been attributed to FAs due to their cytotoxic
action disrupting cell membranes [10], as well as to their role in
modulating inﬂammation [11]. Currently, there is growing interest in
investigating the involvement of these lipid derivatives in diverse
inﬂammatory disorders; however, information about the cellular
mechanisms associated with the FA response is incomplete. Contradic-
tory effects have been reported for individual FAs on different cell
types. Thus, pro-inﬂammatory [12] and no effects [13] have been
found in response to saturated FAs (SFAs). Regarding unsaturated FAs
(UFAs), anti-inﬂammatory [14], pro-inﬂammatory [13,15,16] and no ef-
fects [17] have also been reported. Controversial data may be explained
because the response might be cell dependent and speciﬁc for each FA
according to its chemical structure. So, it is important to assess the
effects exerted by individual UFAs and SFAs on the same cell type as
well as the underlying mechanisms to trigger the cell response.
The effects of different lipid components on pancreatic acini have
not yet been thoroughly investigated despite the relevance they may
have in the pathophysiology of AP. In a recent study [18], we reported
that total lipids aswell as the FA fraction obtained fromnecrotic adipose
tissue of rats with severe AP up-regulated the expression of inﬂamma-
tory mediators in pancreatic acini. Given that in peripancreatic fat ne-
crosis of rats with AP, the most abundant SFAs proved to be palmitic
acid (PA, C16:0) and stearic acid (SA, C18:0), and the major UFAs
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the current study was to assess their individual role in triggering
mechanisms that lead to the inﬂammatory response in acinar cells. As
a representative inﬂammatory mediator with a key role in AP, we ana-
lyzed the expression of chemokine (C–C motif) ligand 2 (CCL2) in pan-
creatic acini exposed to the above-mentioned FAs and the underlying
signaling pathways involved in the FA response. We show that the
most abundant UFAs, but not the SFAs, in necrotic peripancreatic fat
tissue of rats with AP activated molecular pathways which lead to
CCL2 overexpression in acinar cells. The relevance of this study lies in
furthering the understanding of the role of FAs in the pathophysiology
of AP and in the approach of potential therapeutic strategies to the
disease.
2. Materials and methods
2.1. Chemicals
Collagenase type XI, N-(2-hydroxyethyl) piperazine-N′-(2-
ethanesulfonic acid) (HEPES), amino acids solution, bovine serum albu-
min (BSA), palmitic acid, stearic acid, oleic acid, linoleic acid, soybean
trypsin inhibitor (STI), phenylmethanesulfonyl ﬂuoride (PMSF),
dithiothreitol (DTT), digitonin, protease inhibitor cocktail, phosphatase
inhibitor cocktail, Nonidet P-40, SP600125, AG-490 and 15-Deoxy-
Δ(12,14)-prostaglandin J(2) (15d-PGJ2) were supplied by Sigma
Chemical Co. (Madrid, Spain). SB202190 was from Calbiochem
(Darmstadt, Germany). GDC-0994, SH-4-54 and JSH-23were kindly do-
nated by Selleckchem (Munich, Germany). Other standard analytical
grade laboratory reagents were obtained from Merck (Darmstadt,
Germany).
2.2. Animals
MaleWistar rats (250–300 g bodyweight) were supplied by the ex-
perimental animal service of the University of Salamanca (Spain). They
were housed individually in cages, maintained at 22± 1 °C using a 12 h
light/dark cycle and fed with standard laboratory chow (Teklad-Harlan
2014, Mucedola, Milan, Italy) and tap water ad libitum. The animals
were fasted overnight before the experiments but they were allowed
free access to water. The study was performed in accordance with
European Community guidelines (2010/63/EU) and approved by the
Institutional Animal Care and Use Committee of the University of
Salamanca (Spain).
2.3. Isolation and treatment of pancreatic acini
After 12 h fasting and under anesthesia with sodium pentobarbital
(3 mg/100 g body weight, intraperitoneally), pancreas of control rats
was removed in order to isolate pancreatic acini by digestionwith colla-
genase as previously described [18]. Afterwards, pancreatic acini were
resuspended in Na-HEPES solution (pH 7.4) enriched with 14 mM glu-
cose and 1% essential aminoacid mixture and containing 1% (w/v) BSA,
0.01% (w/v) STI, and 0.5 mM CaCl2 and incubated (5% CO2, at 37 °C)
for 1 h in the presence of the following FAs: PA (C16:0), SA (C18:0),
OA (C18:1) and LA (C18:2) or the vehicle (EtOH) at concentrations
≤1% (controls). In some experiments, acini were pre-treated with
SP600125 (50 μM), GDC-0994 (50 μM) or SB202190 (50 μM), as inhib-
itors of JNK, ERK and p38-MAPK, respectively; AG-490 (50 μM) as a JAK
inhibitor; JSH-23 (30 μM), SH-4-54 (10 μM), as inhibitors of NF-κB and
STAT3, respectively; or the vehicle dimethyl sulfoxide (DMSO) at
concentrations ≤0.3%. In another set of experiments, the effect of
PPARγ activation on the FA response was evaluated by incubating
acinar cells with 15d-PGJ2 (10 μM), a speciﬁc PPARγ agonist, added
5 min after initiating the incubation in the absence or presence of
each FA.2.4. Lactate dehydrogenase (LDH) activity
LDH leakage was evaluated as a measurement of the cell damage.
LDH activity was analyzed according to the method of Gutmann and
Wahlefel [19]. Cellular LDH was measured after lysis of pancreatic
acini with a 50 mM Tris–HCl buffer (pH 7.2) containing 50 mM
β-glycerophosphate, 15 mM MgCl2, 15 mM EDTA, 10 mM PMSF,
1 mM DTT and 150 μg/ml digitonin. The released LDH was measured
in the incubation medium. Changes in absorbance due to β-nicotin-
amide dinucleotide+ formation were recorded at 339 nm at 30 °C. We
computed the total LDH and calculated the LDH leakage as percentage
of the total measured inside and outside cells.
2.5. Western blot analysis of MAPKs, JAK, NF-κB and STAT3 activation
Cytoplasmic and nuclear extracts of pancreatic acini were obtained
as previously reported [18]. Samples (30 μg) were individually separat-
ed by 12% SDS-PAGE and electrophoretically transferred to a nitrocellu-
lose membrane. Phospho-MAPKs (p-MAPKs), phospho-JNK (p-JAK)
and IκB-α were analyzed in cytoplasm and p65 and phospho-STAT3
(p-STAT3) in nuclear extracts. Non-speciﬁc binding was blocked by
incubating the blot in Tris-buffered saline (TBS) pH 7.6, containing
0.1% (v/v) Tween 20 and 5% (w/v) nonfat dry milk for 1 h. Afterwards,
blots were incubated with the primary antibody against either each of
the three p-MAPKs (p-JNK, p-ERK, p-p38), p-JAK, IκB-α, p65 or
p-STAT3 (Cell Signaling Technology, Beverly, MA) at 1:1000 dilution
in TBS buffer pH 7.6, containing 0.1% (v/v) Tween 20 and 5% (w/v)
BSA overnight at 4 °C. α-Tubulin and lamin B1 (Cell Signaling Technol-
ogy, Beverly, MA) were used as the load control of cytoplasmic and
nuclear proteins, respectively. After washing with TBS containing 0.1%
Tween 20, the blots were incubated for 1 h at room temperature with
the respective horseradish peroxidase-conjugated secondary antibody
at 1:2000 dilution in TBS buffer pH 7.6, containing 0.1% Tween 20 and
5% (w/v) nonfat dry milk and ﬁnally they were developed for visualiza-
tion. The bands were detected with the Phototope-HRP Detection kit
(Cell Signaling Technology, Beverly, MA). Image J 1.32 software from
http://rsbweb.nih.gov/ij/download.html was used to quantify the
intensity of the bands. Relative protein levelswere calculated compared
to either the α-tubulin or lamin B1 standards. Results are expressed as
fold increase vs control acini.
2.6. Analysis of CCL2mRNA by quantitative reverse transcription-polymerase
chain reaction (qRT-PCR)
Total RNA was isolated from pancreatic acini using the RNAeasy kit
treated with ampliﬁcation grade DNase 1 (Qiagen, Valencia, Spain) ac-
cording to the manufacturer's instructions. The integrity of RNA based
on the presence of well-deﬁned 28S and 18S rRNA bands was assessed
in 1% agarose gel andRNA concentrationwasmeasured by spectrometry.
For ﬁrst strand cDNA synthesis, 1 μg of total RNA was reverse-
transcribed using the iScript cDNA synthesis kit for RT-qPCR (Bio-Rad
Laboratories, Hercules, CA). cDNA was ampliﬁed by a polymerase
chain reaction (PCR) on a StepOne system (Applied Biosystems, CA,
USA) using the IQ SYBR® Green Supermix (Bio-Rad Laboratories) and
speciﬁc primers (Roche) for each gene: chemokine (C–C motif) ligand
2 (CCL2) (NM_031530) forward: 5′-TAGCATCCACGTGCTGTCTC-3′ re-
verse: 5′-CCGACTCATTGGGATCATCT-3′ and 18S (NM_046237) for-
ward: 5′-AGTCCCTGCCCTTTGTACACA-3′ and reverse: 5′-GATCCGAG
GGCCTCACTAAAC-3′. The cDNA was ampliﬁed by 40 cycles of denatur-
ation at 95 °C for 15 s, annealing at 60 °C for 30 s, and extension at 72 °C
for 20 s. Ampliﬁcations were performed in triplicate and the melting
curves were analyzed to validate product speciﬁcity. The ratio of the
relative expression of target genes to 18S (internal standard) was
calculated by using theΔΔCtmethod. Results were expressed as fold in-
crease over untreated cells.
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Results are expressed as means ± SEM and analyzed by one-way
ANOVA followed by a Tukey post-hoc test for multiple comparisons.
Two-way ANOVA was applied in experiments in which two variables
(dose and treatment) were used. p values lower than 0.05 were
considered to be statistically signiﬁcant.
3. Results
3.1. Dose–response of LDH leakage and CCL2 mRNA expression
The measurement of LDH leakage (Fig. 1A) revealed no signiﬁcant
cell injury in pancreatic acini incubated with PA or SA at concentrations
≤1200 μM in comparison with control acini. A rise in LDH leakage
was found in pancreatic acini exposed to increasing concentrations of
OA or LA, reaching statistical (p b 0.01) signiﬁcance at 600 μM and
1200 μM. Signiﬁcant differences were also found between the SFAs
(PA, SA) andUFAs (OA, LA) at 600 μM(p b 0.05) and 1200 μM(p b 0.01).
The expression of acinar CCL2 mRNA in response to FAs is shown in
Fig. 1B. No signiﬁcant change in the acinar expression of CCL2was found
in response to either PA or SA in a range of concentrations of 0–1200 μM.
Conversely, as regards UFAs, CCL2 mRNA expression increased in re-
sponse to OA or LA at 300 μM, but it declined at lethal concentrations.
Signiﬁcant (p b 0.01) differences were also found between the SFAs
(PA, SA) and UFAs (OA, LA) at 300 μM.
No signiﬁcant effect was found in acini exposed to the vehicle.
3.2. Effects of fatty acids on the activation of MAPKs, JAK, NF-κB and STAT3
Activation of MAPKs (JNK, ERK and p38) and JAK was analyzed by
measuring their phosphorylated forms by western blot in cytosolic ex-
tracts (Fig. 2). PA and SA did not exert signiﬁcant effects on eitherFig. 1.Unsaturated fatty acids (UFAs), but not saturated fatty acids (SFAs), induced cell in-
jury and CCL2 up-regulation. Pancreatic acini were incubated for 1 h in the presence of the
following FAs (0–1200 μM): palmitic acid (PA), stearic acid (SA), oleic acid (OA), linoleic
acid (LA) or EtOH, as the vehicle, (controls). A) Cell injury was measured by leakage of
LDH (% of the total LDH measured inside and outside cells). B) mRNA expression of
CCL2 was analyzed by qRT-PCR with 18S as internal standard. Values are means ± SEM
of ﬁve experiments. Two-way ANOVA showed signiﬁcant differences vs control acini
when the effect of concentration was evaluated (**p b 0.01) and vs PA and SA
(♦p b 0.05, ♦♦p b 0.01) when, at each dose, the effect of the different FAs was analyzed.MAPK or JAK activation. By contrast, signiﬁcant increases in p-JNK
(p54, p46), p-ERK (p44, p42), p-p38 and p-JAKwere found in pancreatic
acini exposed to either OA or LA.
Fig. 3 depicts data of the activation of NF-κB (cytosolic IκB-α and nu-
clear p65) and STAT3 transcription factors. No signiﬁcant effect was
exerted by PA or SA on NF-κB or STAT3 activation. In contrast, OA and
LA signiﬁcantly (p b 0.01) reduced the cytosolic levels of IκB-α and
signiﬁcantly increased p65 at the nuclear level. Regarding STAT3 activa-
tion, OA and LA signiﬁcantly (p b 0.01) increased the nuclear p-STAT3
levels.
No change was found in response to the vehicle.
3.3. CCL2 mRNA up-regulation is transcriptionally regulated by NF-κB and
STAT3
As shown in Fig. 4, the acinar CCL2 mRNA up-regulation induced by
OA or LAwas signiﬁcantly (p b 0.01) reduced by pre-treatmentwith the
NF-κB inhibitor JSH-23 as well as with the STAT3 inhibitor SH-4-54.
Nevertheless, the values obtained in acini pre-treatedwith the inhibitors
were still found to be signiﬁcantly (p b 0.01) higher than in untreated
acini.
3.4. Involvement of MAPKs and JAK in the NF-κB- and STAT3-up-regulated
CCL2 mRNA expression
Fig. 5 shows the results obtained by using speciﬁc inhibitors to verify
the role of MAPKs and JAK on the activation of NF-κB and STAT3 as well
as on CCL2mRNAup-regulationmediated byOA or LA. The densitomet-
ric analysis of IκB-α (Fig. 5A) and p65 (Fig. 5B) revealed that SP600125,
GDC-0994 or SB202190, inhibitors of JNK-, ERK- and p38-MAPK, respec-
tively, aswell as AG-490, a JAK inhibitor, signiﬁcantly (p b 0.01) reduced
the OA- or LA-mediated activation of NF-κB. The IκB-α degradation
induced by either OA or LAwas signiﬁcantly (p b 0.01) attenuated by in-
hibition of either JNK, ERK, p38 or JAK. Reciprocally, the increased p65
levels found in the nucleus of pancreatic acini treated with either OA
or LA were signiﬁcantly (p b 0.01) reduced by either each MAPK or
JAK. Similarly, OA- or LA-induced STAT3 activation (Fig. 5C) was signif-
icantly (p b 0.01) reduced in the presence of SP600125, GDC-0994,
SB202190 or AG-490. In the same line, pre-treatment with inhibitors
of either MAPKs or JAK also signiﬁcantly (p b 0.01) decreased the CCL2
mRNA up-regulation mediated by OA or LA (Fig. 5D).
Despite the presence of the inhibitors the nuclear levels of p65 and
STAT3 as well as the CCL2 mRNA expression remained at values
signiﬁcantly higher than in untreated acini.
3.5. Effect of PPARγ activation on the inﬂammatory acinar response
As shown in Fig. 6, the presence of the PPARγ agonist 15d-PGJ2, in
the incubation medium signiﬁcantly reduced the activation of JNK-,
ERK- and p38-MAPK induced by either OA or LA to values not signiﬁ-
cantly different from those of control acini. The PPARγ agonist also re-
pressed the JAK activation mediated by OA or LA. No effect was
exerted by 15d-PGJ2 on control acini.
As can be seen in Fig. 7A and B, 15d-PGJ2 blocked the OA- or LA-
mediated NF-κB activation, by reducing the cytosolic IκB-α degradation
and p65 at the nuclear level. The PPARγ agonist also inhibited the STAT3
activation induced by OA or LA (Fig. 7C). Regarding CCL2mRNA expres-
sion (Fig. 7D), 15d-PGJ2 repressed the CCL2 up-regulation induced by
OA or LA.
4. Discussion
It is increasingly accepted that FAs play a pivotal role in modulating
inﬂammation, but the understanding of the mechanisms involved in
this response remains unclear. Given that they are released in high
amounts from peripancreatic adipose tissue during AP, the assessment
Fig. 2.Unsaturated fatty acids (UFAs), but not saturated fatty acids (SFAs), activatedMAPKs and JAK. Pancreatic acini were incubated for 1 h in the presence of the following FAs (300 μM):
palmitic acid (PA), stearic acid (SA), oleic acid (OA), linoleic acid (LA) or EtOH, as the vehicle, (controls). PhosphorylatedMAPKs (p-MAPKs): c-JunNH2-terminal kinase (JNK), extracellular
signal-regulated kinase (ERK), p38 and phosphorylated Janus kinase (p-JAK) were analyzed in cytoplasmic extracts by western blot. Representative blots of ﬁve experiments (A) and
densitometric analysis of the band intensity (B) are shown. Densities (arbitrary units) were normalized with those of α-tubulin (loading control). Results (means ± SEM) are expressed
as fold increase vs control acini. *p b 0.05, **p b 0.01 as compared with control acini.
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mediators during the disease [20], would give new insights into the
pathophysiology of AP. This proposal would be especially relevant in
the context of obesity given that FAs are massively released from
peripancreatic fat tissue duringAP. Furthermore, obese subjects develop
severe forms of the diseasewith abundant peripancreatic necrosis [5–9]
which have proven to be enriched in UFAs [5].Fig. 3.Unsaturated fatty acids (UFAs), but not saturated fatty acids (SFAs), activatedNF-κB
and STAT3. Pancreatic acini were incubated for 1 h in the presence of the following FAs
(300 μM): palmitic acid (PA), stearic acid (SA), oleic acid (OA), linoleic acid (LA) or
EtOH, as the vehicle (controls). Western blots of cytosolic IκB-α (top), nuclear p65 (mid-
dle) and nuclear phosphorylated STAT3 (p-STAT3) (bottom) are shown. Representative
blots of ﬁve experiments (A) and densitometric analysis of the band intensity (B) are
shown. Densities (arbitrary units) were normalized with those of α-tubulin or lamin B1
(loading control for cytosolic or nuclear proteins, respectively). Results (means ± SEM)
are expressed as fold change vs control acini. *p b 0.05, **p b 0.01 as comparedwith control
acini.Since both pro- and anti-inﬂammatory effects have been reported
for FAs [13,15,17], knowledge of the individual effects of the major
FAs in the fat tissue is of great interest considering that the speciﬁc
action of each FA could determine the fate of this inﬂammatory disease.
The use of the SFAs (PA, SA)with different number of carbon atoms and
the UFAs (OA, LA) with the same carbon but different number of double
bonds will allow us to ascertain whether the acinar response depends
on the FA chemical structure and, in such a case, elucidate which the
key molecular feature is.
In order to mechanistically explain the effects of UFAs and SFAs, we
analyzed the main intracellular signaling pathways involved in the in-
ﬂammatory response in acinar cells. Our data revealed that JNK-, ERK-,
and p38-MAPKs as well as JAK played a key role as upstreams in the
events which led to the CCL2 up-regulation mediated by the UFAs OA
and LA. It is widely accepted that the phosphorylation required for the
transcriptional activation of NF-κB is MAPK-dependent, while the acti-
vation of STAT3 transcription factor is generally associated with JAKFig. 4. CCL2 up-regulation induced by unsaturated fatty acids is dependent on NF-κB and
STAT3. Pancreatic acini exposed for 1 h to 300 μM of oleic acid (OA) or linoleic acid (LA)
were pre-treated for 45 min with the vehicle (DMSO), the NF-κB inhibitor JSH-23
(30 μM) or the STAT3 inhibitor SH-4-54 (10 μM). CCL2 mRNA expression was analyzed
by qRT-PCRwith 18S as internal standard. Results (means± SEM) from ﬁve experiments
are expressed as percentages of the maximal response. **p b 0.01 as compared with un-
treated acini, ♦♦p b 0.01 as compared with OA- or LA-treated acini.
Fig. 5.MAPKs and JAK are upstreams of UFA-induced CCL2 up-regulation transcriptionally mediated by NF-κB and STAT3. Pancreatic acini exposed for 1 h to 300 μM of oleic acid (OA) or
linoleic acid (LA) were pre-treated for 45min with the vehicle (DMSO) or SP600125 (50 μM), GDC-0994 (50 μM) or SB202190 (50 μM), inhibitors of JNK-, ERK- and p38-MAPKs, respec-
tively, or AG-490 (50 μM), JAK inhibitor. Levels of cytosolic IκB-α (A), nuclear p65 (B), and nuclear p-STAT3 (C) were analyzed by western-blot. Representative gels and densitometric
analysis of the band intensity are shown. Densities (arbitrary units) were normalized with those ofα-tubulin or lamin B1 (loading control for cytosolic or nuclear proteins, respectively).
CCL2mRNA expression (D)was analyzed by qRT-PCRwith 18S as internal standard. Results (means± SEM) from ﬁve experiments are expressed as percentages of themaximal response.
*p b 0.05, **p b 0.01 as compared with untreated acini, ♦♦p b 0.01 as compared with OA- or LA-treated acini.
Fig. 6. 15-Deoxy-Δ(12,14)-prostaglandin J(2) (15d-PGJ2) inhibited UFA-mediatedMAPKs and JAK activation. Pancreatic acini incubated for 1 h in the presence of 300 μMof theUFAs oleic
acid (OA) or linoleic acid (LA) or EtOH, as the vehicle, (controls) were cultured with or without 15d-PGJ2 (10 μM). Phosphorylated MAPKs (p-MAPKs): c-Jun NH2-terminal kinase (JNK),
extracellular signal-regulated kinase (ERK), p38 and phosphorylated Janus kinase (p-JAK) were analyzed in cytoplasmic extracts by western blot. Representative gels of ﬁve experiments
(A) and densitometric analysis of the band intensity (B) are shown. Densities (arbitrary units) were normalized with those of α-tubulin (loading control). Results (means ± SEM) are
expressed as fold changes vs control acini. *p b 0.05, **p b 0.01 as compared with control acini, ♦p b 0.05, ♦♦p b 0.01 as compared with OA- or LA-treated acini.
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Fig. 7. 15-Deoxy-Δ(12,14)-prostaglandin J(2) (15d-PGJ2) suppressed UFA-induced CCL2
up-regulation via inhibition of NF-κB and STAT3 pathways. Pancreatic acini incubated
for 1 h in the presence of 300 μM of the UFAs oleic acid (OA) or linoleic acid (LA) or
EtOH, as the vehicle, (controls), were cultured with or without 15d-PGJ2 (10 μM). Repre-
sentative western blots of ﬁve experiments and densitometric analysis of the band inten-
sity of cytosolic IκB-α (A), nuclear p65 (B) and nuclear p-STAT3 (C) are shown. Densities
(arbitrary units) were normalizedwith those ofα-tubulin or lamin B1 (loading control for
cytosolic or nuclear proteins, respectively). CCL2 mRNA expression (D) was analyzed by
qRT-PCR with 18S as internal standard. Results (means ± SEM) are expressed as fold
changes vs control acini. *p b 0.05, **p b 0.01 as compared with control acini, ♦p b 0.05,
♦♦p b 0.01 as compared with OA- or LA-treated acini.
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kinase in the current study indicated that MAPKs as well as JAK are in-
volved in the UFA-mediated activation of both NF-κB and STAT3 tran-
scription factors.
The individual inhibition of these kinases did not totally repress the
CCL2 overexpression induced by either OA or LA, suggesting that JNK-,
p38- and ERK-MAPK and JAK must act in a synergic way on the mecha-
nisms that converge in the CCL2 expression. In addition, the selective in-
hibition of NF-κB and STAT3 activation provides evidence that both
transcription factors contribute to up-regulate mRNA CCL2 expression
in acinar cells stimulated by OA or LA. In line with our results, the in-
volvement of NF-κB in the FA-induced expression of pro-inﬂammatory
genes has also been reported in other endothelial cells [15,23,24] and ad-
ipocytes [25]. However, NF-κB non-dependent mechanisms have also
been demonstrated to mediate inﬂammatory response in dendritic
cells [26] and macrophages [27].
Regarding the STAT3 signal, the current study reinforces the previ-
ously reported notion of the involvement of this pathway in the acinar
inﬂammatory response to lipid components of necrotic adipose tissue
of rats with severe AP [18]. Also, STAT3 activation has demonstrated
to be involved in the inﬂammatory response of acinar cells during AP
[28,29]. Taken together, this indicates that in addition to NF-κB and
AP-1 [20,30,31], the transcriptional activity of STAT3 might be key in
the signaling mechanisms that lead to the expression of inﬂammatory
mediators in acinar cells exposed to stressful conditions.
Peroxisome proliferator-activated receptors (PPARs) are a family of
ligand-inducible transcription factors involved in the lipid-associated
inﬂammatory response [11]. PPARγ has been found to be highly
expressed in pancreatic AR42J cells [32] and pancreatic tissue [33]. By
acting as PPARγ ligands, n-3 PUFAs exerted suppressive effects on in-
ﬂammatory response [34]. Conversely, the pro-inﬂammatory effects in-
duced on macrophages by FAs proved to be the result of interference inthe PPARγ anti-inﬂammatory activity [27]. This interference might be
discarded in pancreatic acinar cells since the activation of the PPARγ
pathway by adding 15d-PGJ2 in the presence of OA or LA resulted in
the total inhibition of the UFA-mediated CCL2 up-regulation. In accor-
dance with this result, PPARγmight not be considered to play a role in
the acinar inﬂammatory response mediated by UFAs. However, the
use of 15d-PGJ2, themost speciﬁc PPARγ agonist [35], allowed us to elu-
cidate the signalingmechanisms triggered by the PPARγ pathway to in-
hibit the UFA-mediated CCL2 overexpression in pancreatic acini. Our
data showed that PPARγ activation prevented the phosphorylation of
MAPKs and JAK and hence the subsequent NF-κB and STAT3 activation.
Consistent with our results, blockage of NF-κB [36] and STAT3 [37] acti-
vation has also been reported in cerulein-stimulated pancreatic AR42J
cells pre-treated with 15d-PGJ2. The current data reinforce the notion
that the use of PPARγ agonists might be considered as a potential ther-
apeutic strategy for reducing inﬂammation during AP [38–40].
In line with our results, CCL2 overexpression in response to LA has
been reported in different cell types [15,41,42], including acinar cells
[13]. However, pro-inﬂammatory [16], anti-inﬂammatory [15] and no
effects [17] have been described for OA. The pro-inﬂammatory action
of OA found in the current study could be the basis to explain the
etiopathology of AP experimentally induced in rats by retrograde perfu-
sion of oleic acid into the pancreatic duct [43,44], such that the CCL2 up-
regulation induced by OA in acinar cells might be the signal to attract
circulating leukocytes to the gland and trigger severe forms of AP.
Hawkins et al. [45] reported that the lipid peroxidation and death of
pancreatic acinar cells in response to FAs are related to the number of
double bonds in the molecule. This ﬁnding led us in a recent study
[18] to suggest that increases in PUFA/MUFA ratio found in necrotic ad-
ipose tissue of rats with severe AP could be responsible for the acinar in-
ﬂammatory response induced by the total free FAs. Data shown in the
current study leads us to dismiss this hypothesis since the CCL2 expres-
sion in acinar cells exposed to effective doses of either OA or LA proved
to be similar.
Regarding the SFA effects, our study showed that both SA and PA
failed to trigger inﬂammatory response in acinar cells. In line with previ-
ous studies [13,46,47], our ﬁndings corroborate the notion that the un-
saturated state of FAs determines the injury and the inﬂammatory
response in pancreatic acinar cells. Taken the UFA and SFA data together,
our study provides evidence that the presence of bonds in the FA mole-
cule, but not the number of double bonds nor the length of the chain, is
the feature that determines the triggering of mechanisms required for
the development of the inﬂammatory response in pancreatic acinar cells.
Our results suggest that UFAs would play a key role in AP such that
they could be the link between obesity and a worse AP outcome. This
notion is supported by a highly pertinent study byNoel et al. [5] who re-
ported that UFAs, found in high concentrations in necrotic collections
from obese patients with AP, are responsible not only for acinar necro-
sis, but also for triggering multisystem organ failure by mechanisms
non-dependent on pancreatic necrosis. All these ﬁndings reinforce the
notion that treatments preventing the generation of UFAs could have
beneﬁcial effects in severe AP.5. Conclusion
This study contributes new information about the cellular
mechanisms bywhich FAs exert differential effects on the inﬂammatory
response triggered in pancreatic acinar cells depending on the
unsaturation state. Our data provide mechanistic evidence that the
most abundant UFAs, but not the major SFAs, in peripancreatic fat and
released during AP, could play a role in the pathophysiology of AP.
They are capable of up-regulating the acinar expression of CCL2 through
the activation of MAPK/JAK-mediated NF-κB and STAT3 pathways. By
targeting both transcription factors, the use of PPARγ agonists could
be indicated as potential therapy in AP.
2677A. Mateu et al. / Biochimica et Biophysica Acta 1852 (2015) 2671–2677Competing interests
The authors declare no competing ﬁnancial interests.
Transparency document
The Transparency document associated with this article can be
found, in the online version.
Acknowledgments
Thanks are due to Elizabeth Nestor for her linguistic assistance. This
work was supported by grants from the Junta Castilla-León, Spain (BIO/
SA63/14) and the University of Salamanca, Spain (USAL 13/18KAL7).
References
[1] S. Domschke, P. Malfertheiner, W. Uhl, M. Buchler, W. Domschke, Free fatty acids in
serum of patients with acute necrotizing or edematous pancreatitis, Int. J.
Pancreatol. 13 (1993) 105–110.
[2] D. Estadella, C.M. Dapenhaollerdonascimento, L.M. Oyama, E.B. Ribeiro, A.R. Damaso,
A. de Piano, Lipotoxicity: effects of dietary saturated and transfatty acids, Mediat.
Inﬂamm. (2013) 137579.
[3] G.H. Sakorafas, A.G. Tsiotou, Etiology and pathogenesis of acute pancreatitis: current
concepts, J. Clin. Gastroenterol. 30 (2000) 343–356.
[4] K. Sztefko, J. Panek, Serum free fatty acid concentration in patients with acute pan-
creatitis, Pancreatology 1 (2001) 230–236.
[5] P. Noel, K. Patel, C. Durgampudi, R.N. Trivedi, C. de Oliveira, M.D. Crowell, R. Pannala,
K. Lee, R. Brand, J. Chennat, A. Slivka, G.I. Papachristou, A. Khalid, D.C. Whitcomb, J.P.
DeLany, R.A. Cline, C. Acharya, D. Jaligama, F.M. Murad, D. Yadav, S. Navina, V.P.
Singh, Peripancreatic fat necrosis worsens acute pancreatitis independent of pancre-
atic necrosis via unsaturated fatty acids increased in human pancreatic necrosis col-
lections, Gut (2014).
[6] L. Sempere, J. Martinez, E. de Madaria, B. Lozano, J. Sanchez-Paya, R. Jover, M. Perez-
Mateo, Obesity and fat distribution imply a greater systemic inﬂammatory response
and a worse prognosis in acute pancreatitis, Pancreatology 8 (2008) 257–264.
[7] G.I. Papachristou, D.J. Papachristou, H. Avula, A. Slivka, D.C. Whitcomb, Obesity in-
creases the severity of acute pancreatitis: performance of APACHE-O score and cor-
relation with the inﬂammatory response, Pancreatology 6 (2006) 279–285.
[8] H.H. Al-Azzawi, T.E. Wade, D.A. Swartz-Basile, S. Wang, H.A. Pitt, N.J. Zyromski,
Acute pancreatitis in obesity: adipokines and dietary ﬁsh oil, Dig. Dis. Sci. 56
(2011) 2318–2325.
[9] R. Segersvard, M. Sylvan, M. Herrington, J. Larsson, J. Permert, Obesity increases the
severity of acute experimental pancreatitis in the rat, Scand. J. Gastroenterol. 36
(2001) 658–663.
[10] Y. Morita, T. Yoshikawa, S. Takeda, K. Matsuyama, S. Takahashi, N. Yoshida, M.G.
Clemens, M. Kondo, Involvement of lipid peroxidation in free fatty acid-induced
isolated rat pancreatic acinar cell injury, Pancreas 17 (1998) 383–389.
[11] C.M. Volpe, J.A. Nogueira-Machado, The dual role of free fatty acid signaling in
inﬂammation and therapeutics, Recent Pat. Endocr. Metab. Immune Drug. Discov.
7 (2013) 189–197.
[12] C.M. Oller do Nascimento, E.B. Ribeiro, L.M. Oyama, Metabolism and secretory func-
tion of white adipose tissue: effect of dietary fat, An. Acad. Bras. Cienc. 81 (2009)
453–466.
[13] S. Navina, C. Acharya, J.P. DeLany, L.S. Orlichenko, C.J. Baty, S.S. Shiva, C. Durgampudi,
J.M. Karlsson, K. Lee, K.T. Bae, A. Furlan, J. Behari, S. Liu, T. McHale, L. Nichols, G.I.
Papachristou, D. Yadav, V.P. Singh, Lipotoxicity causes multisystem organ failure
and exacerbates acute pancreatitis in obesity, Sci. Transl. Med. 3 (2011) 107ra110.
[14] P.C. Calder, n-3 polyunsaturated fatty acids, inﬂammation, and inﬂammatory dis-
eases, Am. J. Clin. Nutr. 83 (2006) 1505S–1519S.
[15] M. Toborek, Y.W. Lee, R. Garrido, S. Kaiser, B. Hennig, Unsaturated fatty acids selec-
tively induce an inﬂammatory environment in human endothelial cells, Am. J. Clin.
Nutr. 75 (2002) 119–125.
[16] I.M. Fang, C.H. Yang, C.M. Yang, M.S. Chen, Comparative effects of fatty acids on pro-
inﬂammatory gene cyclooxygenase 2 and inducible nitric oxide synthase expression
in retinal pigment epithelial cells, Mol. Nutr. Food Res. 53 (2009) 739–750.
[17] S. Gupta, A.G. Knight, S. Gupta, J.N. Keller, A.J. Bruce-Keller, Saturated long-chain
fatty acids activate inﬂammatory signaling in astrocytes, J. Neurochem. 120
(2012) 1060–1071.
[18] A. Mateu, L. Ramudo, M.A. Manso, D. Closa, I. De Dios, Acinar inﬂammatory response
to lipid derivatives generated in necrotic fat during acute pancreatitis, Biochim.
Biophys. Acta 1842 (2014) 1879–1886.
[19] I. Gutmann, A.W.Wahlefel, L-(+)-Lactate determination with lactatodehydrogenase
and NAD, in: H.U. Bergmeyer (Ed.), Methods of Enzymatic Analysis, Academic Press,
New York 1974, pp. 1464–1468.
[20] L. Ramudo, M.A. Manso, S. Sevillano, I. de Dios, Kinetic study of TNF-alpha produc-
tion and its regulatory mechanisms in acinar cells during acute pancreatitis induced
by bile–pancreatic duct obstruction, J. Pathol. 206 (2005) 9–16.
[21] P.C. Heinrich, I. Behrmann, S. Haan, H.M. Hermanns, G. Muller-Newen, F. Schaper,
Principles of interleukin (IL)-6-type cytokine signalling and its regulation, Biochem.
J. 374 (2003) 1–20.[22] Y. Zhang, L.O. Cardell, L. Edvinsson, C.B. Xu, MAPK/NF-kappaB-dependent upregula-
tion of kinin receptors mediates airway hyperreactivity: a new perspective for the
treatment, Pharmacol. Res. 71 (2013) 9–18.
[23] B. Hennig, M. Toborek, S. Joshi-Barve, S.W. Barger, S. Barve, M.P. Mattson, C.J.
McClain, Linoleic acid activates nuclear transcription factor-kappa B (NF-kappa
B) and induces NF-kappa B-dependent transcription in cultured endothelial cells,
Am. J. Clin. Nutr. 63 (1996) 322–328.
[24] B. Hennig, W. Lei, X. Arzuaga, D.D. Ghosh, V. Saraswathi, M. Toborek, Linoleic acid
induces proinﬂammatory events in vascular endothelial cells via activation of
PI3K/Akt and ERK1/2 signaling, J. Nutr. Biochem. 17 (2006) 766–772.
[25] N. Siriwardhana, N.S. Kalupahana, S. Fletcher, W. Xin, K.J. Claycombe, A. Quignard-
Boulange, L. Zhao, A.M. Saxton, N. Moustaid-Moussa, n-3 and n-6 polyunsaturated
fatty acids differentially regulate adipose angiotensinogen and other inﬂammatory
adipokines in part via NF-kappaB-dependent mechanisms, J. Nutr. Biochem. 23
(2012) 1661–1667.
[26] M. Zeyda, M.D. Saemann, K.M. Stuhlmeier, D.G. Mascher, P.N. Nowotny, G.J.
Zlabinger, W. Waldhausl, T.M. Stulnig, Polyunsaturated fatty acids block dendritic
cell activation and function independently of NF-kappaB activation, J. Biol. Chem.
280 (2005) 14293–14301.
[27] P.T. Gutierrez, E. Folch-Puy, O. Bulbena, D. Closa, Oxidised lipids present in ascitic
ﬂuid interfere with the regulation of the macrophages during acute pancreatitis,
promoting an exacerbation of the inﬂammatory response, Gut 57 (2008) 642–648.
[28] S. Yubero, L. Ramudo, M.A. Manso, I. De Dios, The role of redox status on chemokine
expression in acute pancreatitis, Biochim. Biophys. Acta 1792 (2009) 148–154.
[29] S. Yubero, L. Ramudo, M.A. Manso, I. De Dios, Mechanisms of dexamethasone-
mediated chemokine down-regulation in mild and severe acute pancreatitis,
Biochim. Biophys. Acta 1792 (2009) 1205–1211.
[30] L. Ramudo, S. Yubero, M.A. Manso, S. Vicente, I. De Dios, Signal transduction of MCP-
1 expression induced by pancreatitis-associated ascitic ﬂuid in pancreatic acinar
cells, J. Cell. Mol. Med. 13 (2009) 1314–1320.
[31] L.S. Orlichenko, J. Behari, T.H. Yeh, S. Liu, D.B. Stolz, A.K. Saluja, V.P. Singh, Transcrip-
tional regulation of CXC-ELR chemokines KC and MIP-2 in mouse pancreatic acini,
Am. J. Physiol. Gastrointest. Liver Physiol. 299 (2010) G867–G876.
[32] A. Masamune, K. Satoh, Y. Sakai, M. Yoshida, A. Satoh, T. Shimosegawa, Ligands of
peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J
cells, Pancreas 24 (2002) 130–138.
[33] P. Xu, X.L. Lou, C. Chen, Z.W. Yang, Effects of peroxisome proliferator-activated
receptor-gamma activation on apoptosis in rats with acute pancreatitis, Dig. Dis.
Sci. 58 (2013) 3516–3523.
[34] G. Schmitz, J. Ecker, The opposing effects of n-3 and n-6 fatty acids, Prog. Lipid Res.
47 (2008) 147–155.
[35] B.M. Forman, P. Tontonoz, J. Chen, R.P. Brun, B.M. Spiegelman, R.M. Evans, 15-
Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination
factor PPAR gamma, Cell 83 (1995) 803–812.
[36] H. Wan, Y. Yuan, A. Qian, Y. Sun, M. Qiao, Pioglitazone, a PPARgamma ligand,
suppresses NFkappaB activation through inhibition of IkappaB kinase activation in
cerulein-treated AR42J cells, Biomed. Pharmacother. 62 (2008) 466–472.
[37] J.H. Yu, K.H. Kim, H. Kim, SOCS 3 and PPAR-gamma ligands inhibit the expression of
IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas, Int. J. Biochem.
Cell Biol. 40 (2008) 677–688.
[38] K. Hashimoto, R.T. Ethridge, H. Saito, S. Rajaraman, B.M. Evers, The PPARgamma
ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis,
Pancreas 27 (2003) 58–66.
[39] S. Cuzzocrea, B. Pisano, L. Dugo, A. Ianaro, D. Britti, N.S. Patel, R. Di Paola, T. Genovese,
M. Di Rosa, A.P. Caputi, C. Thiemermann, Rosiglitazone, a ligand of the peroxisome
proliferator-activated receptor-gamma, reduces acute pancreatitis induced by
cerulein, Intensive Care Med. 30 (2004) 951–956.
[40] P. Xu, K. Xu, J. Wang, J.P. Jiang, L.Q. Chen, Pioglitazone: a promising therapeutic tool
in sodium taurocholate-induced severe acute pancreatitis, Dig. Dis. Sci. 56 (2011)
1082–1089.
[41] Y.F. Jiang, M.I. Vaccaro, F. Fiedler, E.L. Calvo, J.L. Iovanna, Lipopolysaccharides induce
p8 mRNA expression in vivo and in vitro, Biochem. Biophys. Res. Commun. 260
(1999) 686–690.
[42] M.T. Nguyen, A. Chen,W.J. Lu,W. Fan, P.P. Li, D.Y. Oh, D. Patsouris, Regulation of che-
mokine and chemokine receptor expression by PPARgamma in adipocytes andmac-
rophages, PLoS One 7 (2012), e34976.
[43] T. Yamaguchi, H. Nakamura, Y. Kihara, M. Taguchi, H. Yoshikawa, M. Otsuki, Long-
term overexpression of membrane type-1 matrix metalloproteinase and matrix
metalloproteinase-2 in oleic acid-induced pancreatitis in rats, Pancreas 24 (2002)
348–356.
[44] M. Tashiro, H. Nakamura, M. Taguchi, T. Yamaguchi, H. Yoshikawa, K. Fukumitsu, Y.
Kihara, M. Otsuki, Oleic acid-induced pancreatitis alters expression of transforming
growth factor-beta1 and extracellular matrix components in rats, Pancreas 26
(2003) 197–204.
[45] R.A. Hawkins, K. Sangster, M.J. Arends, Apoptotic death of pancreatic cancer cells in-
duced by polyunsaturated fatty acids varies with double bond number and involves
an oxidative mechanism, J. Pathol. 185 (1998) 61–70.
[46] J. Mossner, H. Bodeker,W. Kimura, F. Meyer, S. Bohm,W. Fischbach, Isolated rat pan-
creatic acini as a model to study the potential role of lipase in the pathogenesis of
acinar cell destruction, Int. J. Pancreatol. 12 (1992) 285–296.
[47] D.N. Criddle, J. Murphy, G. Fistetto, S. Barrow, A.V. Tepikin, J.P. Neoptolemos, R.
Sutton, O.H. Petersen, Fatty acid ethyl esters cause pancreatic calcium toxicity via
inositol trisphosphate receptors and loss of ATP synthesis, Gastroenterology 130
(2006) 781–793.
